Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Ramadan, Rabiea; | Koryem, Islam M.b | Fayed, Haythamb
Affiliations: [a] Department of Surgery, Medical Research Institute, Alexandria University, Alexandria, Egypt | [b] Department of Surgery, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Correspondence: [*] Corresponding author: Rabie Ramadan MD, Department of Surgery, Medical Research Institute, Alexandria University, 165 El-Horreya Avenue, El-Hadra 21561m, Alexandria, Egypt. Tel.: +203 4285455 – 4282373 – 4288233; Mobile: 00201222651127; Fax: +203 4283719; E-mail: rr_mri.surg@yahoo.com. ORCIDs: https://orcid.org/0000-0002-5776-2837 (Rabie Ramadan); https://orcid.org/0000-0001-6334-6250 (Islam M. Koryem); https://orcid.org/0000-0001-9971-2320 (Haytham Fayed)
Abstract: BACKGROUND:IGM has a diagnostic and treatment dilemma. The etiology of IGM is unknown but some conditions have been discussed as predisposing factors including Oral Contraceptive Pills, pregnancy, breast feeding, reproductive age, hyperprolactinemia, infectious and autoimmune diseases. The current study aimed to determine possible risk factors for IGM and to evaluate our experience in its management. PATIENTS AND METHODS:The study included forty patients with IGM and forty females with normal breasts as a control group. CST treatment was initiated for all patients; patients who responded completely were followed up without surgical intervention. Failure to respond to medical therapy or incidence of corticosteroid-related complications were considered indications for surgical treatment. All patients were followed up for 6 months to detect recurrence. RESULTS:IGM had a significant higher incidence rate in young females within 5 years from the last lactation, smokers, those with hypperprolactinaemia, who had a history of breast feeding and those who received OCP (P = <0.001, <0.001, 0.006, 0.001, 0.023 and 0.027 respectively). The central part of the breast was more affected (9 cases (22.5%)). Multicenteric disease affected 8 cases (20%). Breast Mass was the most common presenting sign. After CST; the mass disappeared in 5 cases (12.5%), mass size reduced in 26 cases (65%) and mass size not affected in 9 cases (22.5%). Surgery was done in whom the mass size was reduced or not affected (35 cases (87.5%)). Disease recurrence was reported in 2 cases (5.7%). CONCLUSION:IGM usually affects females in their childbearing period with multiple risk factors mainly parity, smoking, OCP and breast feeding with wide variation regarding the presenting manifestations. We should start with CST as there is always a chance to avoid unnecessary surgery and combination of both modalities can reduce the incidence of recurrence.
Keywords: Idiopathic granulomatous mastitis, corticosteroid therapy, Recurrent mastitis
DOI: 10.3233/BD-220047
Journal: Breast Disease, vol. 41, no. 1, pp. 413-420, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl